TRIL
Trillium Therapeutics Inc.
TRIL
TRIL
Delisted
TRIL was delisted on the 16th of November, 2021.
29 hedge funds and large institutions have $27.6M invested in Trillium Therapeutics Inc. in 2016 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 8 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
29
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$725K | |
| 2 | +$588K | |
| 3 | +$263K | |
| 4 |
ECM
Endurant Capital Management
San Mateo,
California
|
+$133K |
| 5 |
KPF
K2 Principal Fund
Toronto,
Ontario, Canada
|
+$131K |
Top Sellers
| 1 | -$1.25M | |
| 2 | -$472K | |
| 3 | -$312K | |
| 4 |
PA
Perceptive Advisors
New York
|
-$278K |
| 5 |
Renaissance Technologies
New York
|
-$236K |